Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers

Aims: While excessive sitting time is related adversely to cardio-metabolic health, it is unknown whether standing is a suitable replacement activity or whether ambulatory movement is required. Using isotemporal substitution analyses, we modelled cross-sectional associations with cardio-metabolic ri...

Full description

Bibliographic Details
Main Authors: Healy, Genevieve, Winkler, E., Owen, N., Anuradha, S., Dunstan, D.
Format: Journal Article
Published: 2015
Online Access:http://hdl.handle.net/20.500.11937/38881
_version_ 1848755439757426688
author Healy, Genevieve
Winkler, E.
Owen, N.
Anuradha, S.
Dunstan, D.
author_facet Healy, Genevieve
Winkler, E.
Owen, N.
Anuradha, S.
Dunstan, D.
author_sort Healy, Genevieve
building Curtin Institutional Repository
collection Online Access
description Aims: While excessive sitting time is related adversely to cardio-metabolic health, it is unknown whether standing is a suitable replacement activity or whether ambulatory movement is required. Using isotemporal substitution analyses, we modelled cross-sectional associations with cardio-metabolic risk biomarkers of reallocating time (2 h/day) from sitting to standing or to stepping.Methods and results: A subsample of participants from the 2011/12 Australian Diabetes, Obesity, and Lifestyle Study wore the posture-based activPAL3 monitor [36–80 years (mean 57.9, SD 9.9 years); 57% women; n = 698 with data]. Associations of activPAL3-derived mean daily time sitting/lying (sitting), standing and stepping with body mass index (BMI), waist circumference, blood pressure, HbA1c, fasting glucose and lipids (high-density lipoprotein-, HDL, and low-density lipoprotein-cholesterol, total/HDL-cholesterol ratio, and triglycerides), and 2-h plasma glucose were examined. Adjusted for relevant confounders, sitting-to-standing reallocations were only significantly (P < 0.05) associated with approximately 2% lower fasting plasma glucose, 11% lower triglycerides, 6% lower total/HDL-cholesterol ratio, and 0.06 mmol/L higher HDL-cholesterol per 2 h/day. Sitting-to-stepping reallocations were only significantly associated with approximately 11% lower BMI, 7.5 cm lower waist circumference, 11% lower 2-h plasma glucose, 14% lower triglycerides, and 0.10 mmol/L higher HDL-cholesterol per 2 h/ day, while standing-to-stepping reallocations were only significantly associated with ∼10% lower BMI, 7 cm lower waist circumference, and 11% lower 2-h plasma glucose.Conclusion: Findings suggested that sitting-reduction strategies targeting increased standing, stepping, or both, may benefit cardio-metabolic health. Standing is a simple alternative to sitting, and requires further examination in prospective and intervention studies.
first_indexed 2025-11-14T08:56:20Z
format Journal Article
id curtin-20.500.11937-38881
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:56:20Z
publishDate 2015
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-388812017-09-13T14:15:06Z Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers Healy, Genevieve Winkler, E. Owen, N. Anuradha, S. Dunstan, D. Aims: While excessive sitting time is related adversely to cardio-metabolic health, it is unknown whether standing is a suitable replacement activity or whether ambulatory movement is required. Using isotemporal substitution analyses, we modelled cross-sectional associations with cardio-metabolic risk biomarkers of reallocating time (2 h/day) from sitting to standing or to stepping.Methods and results: A subsample of participants from the 2011/12 Australian Diabetes, Obesity, and Lifestyle Study wore the posture-based activPAL3 monitor [36–80 years (mean 57.9, SD 9.9 years); 57% women; n = 698 with data]. Associations of activPAL3-derived mean daily time sitting/lying (sitting), standing and stepping with body mass index (BMI), waist circumference, blood pressure, HbA1c, fasting glucose and lipids (high-density lipoprotein-, HDL, and low-density lipoprotein-cholesterol, total/HDL-cholesterol ratio, and triglycerides), and 2-h plasma glucose were examined. Adjusted for relevant confounders, sitting-to-standing reallocations were only significantly (P < 0.05) associated with approximately 2% lower fasting plasma glucose, 11% lower triglycerides, 6% lower total/HDL-cholesterol ratio, and 0.06 mmol/L higher HDL-cholesterol per 2 h/day. Sitting-to-stepping reallocations were only significantly associated with approximately 11% lower BMI, 7.5 cm lower waist circumference, 11% lower 2-h plasma glucose, 14% lower triglycerides, and 0.10 mmol/L higher HDL-cholesterol per 2 h/ day, while standing-to-stepping reallocations were only significantly associated with ∼10% lower BMI, 7 cm lower waist circumference, and 11% lower 2-h plasma glucose.Conclusion: Findings suggested that sitting-reduction strategies targeting increased standing, stepping, or both, may benefit cardio-metabolic health. Standing is a simple alternative to sitting, and requires further examination in prospective and intervention studies. 2015 Journal Article http://hdl.handle.net/20.500.11937/38881 10.1093/eurheartj/ehv308 unknown
spellingShingle Healy, Genevieve
Winkler, E.
Owen, N.
Anuradha, S.
Dunstan, D.
Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers
title Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers
title_full Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers
title_fullStr Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers
title_full_unstemmed Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers
title_short Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers
title_sort replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers
url http://hdl.handle.net/20.500.11937/38881